Asia Pacific Facial Injectable Market Size & Outlook

Name: Asia Pacific Facial Injectable Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The facial injectable market in Asia Pacific is expected to reach a projected revenue of US$ 7,126.5 million by 2033. A compound annual growth rate of 9.2% is expected of Asia Pacific facial injectable market from 2026 to 2033.

Asia Pacific facial injectable product outlook (Revenue, USD million, 2021-2033)
- Collagen and PMMA Microspheres
- Hyaluronic Acid
  - Monophasic
  - Biphasic
- Calcium Hydroxylapatite (CaHA)
- PLLA
- PCL
- PN/PDRN
- Botulinum Toxin (Botox)
- Exosome
Asia Pacific facial injectable applications outlook (Revenue, USD million, 2021-2033)
- Wrinkle Correction
- Lip Augmentation
- Facial Contouring
- Scar Treatment
- Volume Loss Restoration
- Others
Asia Pacific facial injectable end use outlook (Revenue, USD million, 2021-2033)
- MedSpas
- Aesthetic Surgery Centers
- Hospitals
- Others

Asia Pacific Facial Injectable Market Size & Outlook

Sign up - it's easy, and free!